Polyrizon Ltd.
RAANANA, L3 · CIK 0001893645 · Biotech · Private
Intranasal drug delivery platform and formulations
polyrizon-biotech.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $7.5M
- 2 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,499,992 | |
| Private capital raised | Form D · SEC | $3,999,996 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3376 | UNCO THERAPEUTICS LLC | — | — |
| 3377 | Inspira Therapeutics, Inc | — | — |
| 3378 | SYGNAMAP, INC. | — | — |
| 3379 | Polyrizon Ltd. | — | $7.5M |
| 3380 | BlossomHill Therapeutics | — | $246M |
| 3381 | Shattuck Labs, Inc. | — | $164M |
| 3382 | Colossal Biosciences | — | $150M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Oz AdlerDirector
- Liron CarmelDirector
- Asaf ItzhaikDirector
- Tomer IzraeliDirector · Executive Officer
- Eyal RonExecutive Officer
- Liat SidiDirector
- Tidhar TurgemanExecutive Officer
- Yehonatan VinokurDirector
- Nir YosefExecutive Officer
Patents
- MUCOADHESlVE POLYMERS FOR NASAL DRUG DELIVERYapplication
- Method For Removal Of Toxins From Mucosal Membranesapplication
- Mucoadhesive Polymers For Nasal Drug Deliveryapplication
- Mucoadhesive Polymers For Nasal Drug Deliveryapplication
- Mucoadhesive Polymers For Nasal Drug Deliveryapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.